Hyperbaric Oxygen and UV Light for Vitiligo Treatment
Part of Skin clinical trials.
This trial tests whether combining hyperbaric oxygen therapy (breathing high-pressure oxygen in a chamber) with a specific type of ultraviolet light can help restore skin color in people with vitiligo. Vitiligo is a condition where patches of skin lose their pigment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with non-segmental vitiligo (the spreading kind, not the isolated kind) for at least 3 months
- Age 18 or older
- Vitiligo covers 4–60% of your body surface area, with at least 0.5% on your face
- No recent skin cancer, severe sun sensitivity, or conditions that weaken your immune system
- Not pregnant, breastfeeding, or planning pregnancy during the study
- Able to attend all study visits and follow the treatment schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a type of light therapy (narrow-band UVB) to a daily pill called ritlecitinib works better than the pill alone for treating vitiligo. It may help if you have non-segmental vitiligo covering a moderate amount of skin.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This trial tests whether combining microneedling (tiny needle pricks to stimulate skin) with minoxidil cream, with or without special UV light therapy, can help restore skin color in people with stable vitiligo. It aims to find the most effective treatment combination for this skin condition.
This trial tests whether adding a daily nasal spray (Melanotan II) to light therapy helps restore color in stable vitiligo patches. It may be a good option for adults with mild to moderate nonsegmental vitiligo that hasn't changed in at least 6 months.
This trial tests whether combining narrowband UVB light with topical steroids can help treat vitiligo, and looks at specific blood markers (CXCL11 and TEMRA) to see how the treatment affects the immune system. It may help patients with stable, non-segmental vitiligo who have not used systemic therapy in the last 3 months.
This study tests whether special particles derived from umbilical cord stem cells can help restore skin color in vitiligo (a condition causing loss of skin pigmentation). The treatment is being tested in adults with vitiligo affecting 1–30% of their body.
Hear when a new Vitiligo Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.